BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aller MA, Heras NL, Nava MP, Regadera J, Arias J, Lahera V. Splanchnic-aortic inflammatory axis in experimental portal hypertension. World J Gastroenterol 2013; 19(44): 7992-7999 [PMID: 24307792 DOI: 10.3748/wjg.v19.i44.7992] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Karpova RV, Russkova KS, Lavrentieva YN. Increases in Autoantibody Level Associated with Degenerative Changes in the Intestinal Mucosa in Liver Cirrhosis. Clin Exp Gastroenterol 2020;13:315-20. [PMID: 32904688 DOI: 10.2147/CEG.S263176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Angeles Aller M, Blanco-rivero J, Arias A, Arias J. The Wound-Healing Portal Hypertensive Response. Translational Studies on Inflammation 2020. [DOI: 10.5772/intechopen.84689] [Reference Citation Analysis]
3 Licks F, Hartmann RM, Schemitt E, Colares JR, Fillmann LS, Fillmann H, Marroni NP. Inflammatory bowel and oxidative stress changes in an experimental model of portal hypertension: action of N-acetylcysteine. Journal of Coloproctology 2016;36:231-239. [DOI: 10.1016/j.jcol.2016.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Vonghia L, Magrone T, Verrijken A, Michielsen P, Van Gaal L, Jirillo E, Francque S. Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features. PLoS One 2015;10:e0143380. [PMID: 26599575 DOI: 10.1371/journal.pone.0143380] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
5 Zarzavadjian Le Bian A, Costi R, Sbai-Idrissi MS, Smadja C. Liver resection and metabolic disorders: An undescribed mechanism leading to postoperative mortality. World J Gastroenterol 2014; 20(39): 14455-14462 [PMID: 25339832 DOI: 10.3748/wjg.v20.i39.14455] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
6 Manti S, Marseglia L, D'Angelo G, Filippelli M, Cuppari C, Gitto E, Romano C, Arrigo T, Salpietro C. Portal hypertension as immune mediate disease. Hepat Mon 2014;14:e18625. [PMID: 24976841 DOI: 10.5812/hepatmon.18625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]